Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Update: Teladoc Health Q3 Adj. EPS $(0.20) Beats $(0.27) Estimate, Sales $626.439M Beat $625.913M Estimate

Author: Benzinga Newsdesk | October 29, 2025 03:57pm
Teladoc Health (NYSE:TDOC) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.27) by 24.81 percent. This is a 5.26 percent decrease over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $626.439 million which beat the analyst consensus estimate of $625.913 million by 0.08 percent. This is a 2.20 percent decrease over sales of $640.508 million the same period last year.

Posted In: TDOC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist